Overview of the European and North American studies on HPV testing in primary cervical cancer screening

By Jack Cuzick, C. Clavel, K. Petry, C. Meijer, H. Hoyer, S. Ratnam, A. Szarewski, P. Birembaut, S. Kulasingam, P. Sasieni and 1 more. International Journal of Cancer, 2006

1,178 citations recorded by the source corpus.

Subfields: Epidemiology, Microbiology, Surgery

View Paper: https://www.semanticscholar.org/paper/4f9aede9301cbc5f716b255f505b88ebc06e8b70

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. S. Kjaer
2. S. de Sanjosé
3. M. Arbyn
4. M. Stanley

In Surgery

1. S. Kjaer
2. M. Stanley

Citations in the corpus

• Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study (2008, background): “and both meta-analyses and pooled analyses of cross sectional studies have established that tests for human papillomavirus (HPV) have higher sensitivity than cytology in detecting high grade cervical intraepithelial lesions (CIN)”
• Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women of 30 years and older (2009, background): “4%).(11) In addition, in recent prospective screening trials, hc2 sensitivities were 97.”